Pages that link to "Q37120685"
Jump to navigation
Jump to search
The following pages link to P-glycoprotein function at the blood-brain barrier imaged using 11C-N-desmethyl-loperamide in monkeys (Q37120685):
Displaying 36 items.
- PET radiotracers: crossing the blood-brain barrier and surviving metabolism (Q33585028) (← links)
- P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide (Q33797745) (← links)
- N-desmethyl-loperamide is selective for P-glycoprotein among three ATP-binding cassette transporters at the blood-brain barrier (Q33891067) (← links)
- Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood-brain barrier: a comparison with rat data (Q34100185) (← links)
- Regional P-glycoprotein activity and inhibition at the human blood-brain barrier as imaged by positron emission tomography (Q34125735) (← links)
- Lysosomal trapping of a radiolabeled substrate of P-glycoprotein as a mechanism for signal amplification in PET (Q34572780) (← links)
- Increased permeability-glycoprotein inhibition at the human blood-brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar (Q35831488) (← links)
- Behavioral effects and central nervous system levels of the broadly available κ-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo (Q35996706) (← links)
- Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission Tomography (Q36049576) (← links)
- Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study (Q36186141) (← links)
- A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier (Q36386154) (← links)
- Modeling cyclosporine A inhibition of the distribution of a P-glycoprotein PET ligand, 11C-verapamil, into the maternal brain and fetal liver of the pregnant nonhuman primate: impact of tissue blood flow and site of inhibition (Q36525662) (← links)
- Advances in PET imaging of P-glycoprotein function at the blood-brain barrier (Q36638627) (← links)
- Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET. (Q36947632) (← links)
- Imaging of P-glycoprotein function and expression to elucidate mechanisms of pharmacoresistance in epilepsy (Q36947636) (← links)
- A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood-brain barrier with (R)-11C-verapamil and PET (Q36949068) (← links)
- Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor (Q36949086) (← links)
- Synthesis and small-animal positron emission tomography evaluation of [11C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrier (Q36949089) (← links)
- Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[(11)C]verapamil PET. (Q36949815) (← links)
- Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [11C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate (Q36949864) (← links)
- PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo (Q36953090) (← links)
- A novel positron emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood-brain barrier (Q36955931) (← links)
- A review of imaging agent development (Q37214528) (← links)
- Suggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies (Q37217782) (← links)
- Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications (Q37353400) (← links)
- Drug interactions at the blood-brain barrier: fact or fantasy? (Q37362486) (← links)
- Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein (Q37474224) (← links)
- P-glycoprotein related drug interactions: clinical importance and a consideration of disease states (Q37732337) (← links)
- Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier. (Q38166961) (← links)
- Using positron emission tomography to study transporter-mediated drug-drug interactions in tissues (Q38200490) (← links)
- Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions. (Q38844653) (← links)
- Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine-A New Tracer in Clinical Translation for Imaging of σ₁ Receptors. (Q39420068) (← links)
- Imaging P-glycoprotein function in rats using [(11)C]-N-desmethyl-loperamide (Q39437473) (← links)
- Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrier. (Q41823653) (← links)
- Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET (Q57792155) (← links)
- Test-Retest Repeatability of [18F]MC225-PET in Rodents: A Tracer for Imaging of P-gp Function (Q92800442) (← links)